Paul Mampilly is an investor with an outstanding track record. He is currently a senior editor at Banyan Hill Publishing. Mr. Mampilly writes a monthly newsletter called “Profits Unlimited”. This newsletter contains Mr. Mampilly’s stock pick of the month, and the newsletter contains his model portfolio so that investors will be able to have a diversified portfolio based on Mr. Mampilly’s favored stocks.
Before coming on board at Banyan Hill Publishing, Mr. Mampilly worked at Kinetics Asset Management. He is a graduate of Fordham University with an MBA obtained in 1991.
Recently, Paul Mampilly was interviewed by Eric Dye for Enterprise Radio. In the interview, Mr. Mampilly discussed some of his investment habits, and he offered some advice to investors.
During the course of the interview, Mr. Mampilly emphasized what sets him apart from many of the other investment advisors that people can choose to listen to. He emphasized the fact that he works harder than anyone that he knows in order to obtain the information that is necessary to make accurate investment picks. He works as much as 14 hours a day. Much of this time is spent on reading as much as he can about those investments that he is considering.
When asked about the biggest changes that he has seen in the stock market over the last 20 years, Mr. Mampilly pointed to the change in technology and the rise of Exchange Traded Funds (ETFs). Computers are of vital importance at this time on the stock exchanges. Computerized trading can cause the market to drop precipitously in a matter of minutes. ETFs are available in almost every investment sector imaginable. These investment vehicles have become extremely popular among investors as they provide an easy means of diversification.
The question arose during Mr. Mampilly’s discussion on the radio about what mistakes investors seem to make the most. Mr. Mampilly believes that the biggest mistake is when investors put all of their money on a single stock. If that stock should move significantly downward, the investor will have a serious loss. He also believes that investors make a mistake by trying to time the market based on their feelings. Instead of going by feelings, investors need to get in or out of the market based on sound analysis.
One area of investing that Paul Mampilly is really excited about is the area of precision medicine. This type of medicine refers to specific treatments geared toward individuals. For instance, some scientists are studying how an individual’s DNA can be used to devise a cancer treatment that is unique to the individual.
Currently, there are a number of biotech companies that are on the cutting edge of developing precision medicine solutions. Mr. Mampilly believes that this is the way that the majority of medical treatments are heading into the future. If investors are able to get in on the ground floor of some of these biotech companies’ breakthroughs, the investors will be able to see a substantial return on their investment over a period of time.
Mr. Mampilly has a solid history of stock market success. His opinions on various stocks and investments are available through Banyan Hill Publishing.
Love Counting My Pennies?
Sign up to get our latest content by email.